Intraperitoneal mitoxantrone as consolidation treatment for patients with ovarian carcinoma in pathologic complete remission

This publication has 14 references indexed in Scilit:

• Clinical pharmacokinetics of mitoxantrone after intraperitoneal administration
  Cancer Chemotherapy and Pharmacology, 1992
• Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma
  Gynecologic Oncology, 1992
• Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.
  BMJ, 1991
• Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy
  Gynecologic Oncology, 1991
• Survival of patients with ovarian epithelial carcinomas after second-look laparotomy
  Gynecologic Oncology, 1990
• High-dose melphalan and autologous bone marrow support for treatment of ovarian carcinoma with positive second-look operation
  Gynecologic Oncology, 1989
• Second-look procedures in ovarian cancer patients receiving six vs. Nine courses of platinum, adriamycin, cytoxan (PAC) chemotherapy: The SCPMG experience 1982–1985
  Gynecologic Oncology, 1989
• FAILURE OF SECOND-LOOK LAPAROTOMY TO INFLUENCE SURVIVAL IN EPITHELIAL OVARIAN CANCER
  The Lancet, 1988
• Abdominopelvic irradiation for stage II–IV ovarian carcinoma patients with limited or no residual disease at second-look laparotomy after completion of cisplatinum-based combination chemotherapy
  Gynecologic Oncology, 1986
• COMPLETE REMISSION AT LAPAROTOMY: STILL A GOLD STANDARD IN OVARIAN CANCER?
  The Lancet, 1986